Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04326738Phase 1Completed
Phase 1, randomised trial of midazolam (2 arms), sponsored by Yangzhou University. Primary endpoint: itching measured by visual analogue scores at 3 minutes. Started Jan 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04326738.